Michael Ezekowitz, MD | |
1999 Sproul Rd, Ste 26, Broomall, PA 19008-3508 | |
(610) 353-6400 | |
(610) 525-2114 |
Full Name | Michael Ezekowitz |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 54 Years |
Location | 1999 Sproul Rd, Broomall, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366413296 | NPI | - | NPPES |
00180241420003 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | MD070937L (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
Entity Name | Michael D Ezekowitz Md,inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477845246 PECOS PAC ID: 7416122288 Enrollment ID: O20111206000165 |
News Archive
Dynavax Technologies Corporation (Nasdaq:DVAX) today announced the initiation of a Phase 3 registration trial for HEPLISAVTM hepatitis B vaccine in individuals with chronic kidney disease. A second registration trial, a Phase 3 lot-to-lot consistency trial, is expected to begin in early 2010. HEPLISAV is an investigational adult hepatitis B vaccine designed to provide increased, rapid protection with fewer doses than current licensed vaccines.
California Assemblyman Bill Monning, chair of the Assembly Committee on Health introduced AB 1453, which laid out a plan for what essential benefits will be covered in California under the Affordable Care Act. The proposed set of benefits is modeled on the Kaiser small group HMO plan
Boehringer Ingelheim and Priaxon entered into a worldwide collaboration to research and develop mdm2/p53 inhibitors for the treatment of cancer. Priaxon is providing its innovative and proprietary small molecule drug discovery expertise which is particularly suited to investigate inhibition of protein-protein interactions. p53 is a human tumor suppressor protein.
Four researchers at the U.S. Department of Energy's (DOE) Argonne National Laboratory lead projects that have been awarded a total of 65 million hours of computing time on Argonne's energy-efficient Blue Gene/P ("Intrepid") supercomputer. The researchers will conduct advanced simulation and analysis, performing virtual experiments that would be almost impossible and impractical in the natural world. They will also develop scalable system software needed to fully harness the power of supercomputers.
The injectable, multi-dose H1N1 vaccine contains the mercury-based preservative thimerosol to reduce risks of bacterial contamination. The presence of thimerosol has once again raised concerns whether there are risks posed to children when the tiny amount of mercury contained in thimerosol is included in a vaccine.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Michael Ezekowitz, MD 214 N Ithan Ave, Villanova, PA 19085-1936 Ph: (610) 353-6400 | Michael Ezekowitz, MD 1999 Sproul Rd, Ste 26, Broomall, PA 19008-3508 Ph: (610) 353-6400 |
News Archive
Dynavax Technologies Corporation (Nasdaq:DVAX) today announced the initiation of a Phase 3 registration trial for HEPLISAVTM hepatitis B vaccine in individuals with chronic kidney disease. A second registration trial, a Phase 3 lot-to-lot consistency trial, is expected to begin in early 2010. HEPLISAV is an investigational adult hepatitis B vaccine designed to provide increased, rapid protection with fewer doses than current licensed vaccines.
California Assemblyman Bill Monning, chair of the Assembly Committee on Health introduced AB 1453, which laid out a plan for what essential benefits will be covered in California under the Affordable Care Act. The proposed set of benefits is modeled on the Kaiser small group HMO plan
Boehringer Ingelheim and Priaxon entered into a worldwide collaboration to research and develop mdm2/p53 inhibitors for the treatment of cancer. Priaxon is providing its innovative and proprietary small molecule drug discovery expertise which is particularly suited to investigate inhibition of protein-protein interactions. p53 is a human tumor suppressor protein.
Four researchers at the U.S. Department of Energy's (DOE) Argonne National Laboratory lead projects that have been awarded a total of 65 million hours of computing time on Argonne's energy-efficient Blue Gene/P ("Intrepid") supercomputer. The researchers will conduct advanced simulation and analysis, performing virtual experiments that would be almost impossible and impractical in the natural world. They will also develop scalable system software needed to fully harness the power of supercomputers.
The injectable, multi-dose H1N1 vaccine contains the mercury-based preservative thimerosol to reduce risks of bacterial contamination. The presence of thimerosol has once again raised concerns whether there are risks posed to children when the tiny amount of mercury contained in thimerosol is included in a vaccine.
› Verified 7 days ago
Dr. Julian L Gladstone, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1999 Sproul Rd, Ste 21, Broomall, PA 19008 Phone: 610-353-6400 Fax: 610-356-1836 | |
John D Sprandio, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 30 Lawrence Rd, Suite 201, Broomall, PA 19008 Phone: 610-492-5900 Fax: 610-492-5810 | |
Walter Kornienko, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 30 Lawrence Rd Ste 800, Broomall, PA 19008 Phone: 610-848-7000 Fax: 610-325-2016 | |
Dr. Larry M Shrager, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2000 Sproul Rd Suite 100, Marple Commons, Broomall, PA 19008 Phone: 610-353-3500 Fax: 610-353-2015 | |
Dr. Margaret Elaine Walker, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2000 Sproul Rd, Suite 300, Broomall, PA 19008 Phone: 610-359-1355 Fax: 610-359-9228 | |
Dr. Laura Kathryn Gallo, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1991 Sproul Rd Ste 625, Broomall, PA 19008 Phone: 610-325-0309 Fax: 610-325-0459 | |
Stephen A Shore, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 30 Lawrence Rd, Suite 201, Broomall, PA 19008 Phone: 610-492-5900 Fax: 610-492-5903 |